$CUTR
CUTERA INC Stock $cutr

$cutr Overview Financials Valuation SEC Filings Company Website

2020 Q4 Form 10-K Financial Statement

#000143774921006866 Filed on March 23, 2021

Income Statement

Concept	2020 Q4	2020 Q3	2020 Q2
Revenue	$49.94M	$39.13M	$26.37M
YoY Change	-3.58%	-15.15%	-44.8%
Cost Of Revenue	$21.88M	$17.39M	$14.75M
YoY Change	-4.9%	-12.56%	-32.8%
Gross Profit	$28.07M	$21.75M	$11.62M
YoY Change	-2.51%	-17.1%	-55.0%
Gross Profit Margin	56.2%	55.57%	44.08%
Selling, General & Admin	$22.59M	$19.53M	$19.56M
YoY Change	-13.95%	-21.9%	-12.11%
% of Gross Profit	80.5%	89.79%	168.31%
Research & Development	$4.029M	$3.432M	$2.991M
YoY Change	-9.72%	-5.79%	-8.62%
% of Gross Profit	14.36%	15.78%	25.73%
Depreciation & Amortization	$330.0K	$340.0K	$360.0K
YoY Change	-10.81%	-5.56%	-12.2%
% of Gross Profit	1.18%	1.56%	3.1%
Operating Expenses	$26.62M	$22.96M	$22.56M
YoY Change	-13.33%	-19.85%	-11.66%
Operating Profit	$1.443M	-$1.211M	-$10.93M
YoY Change	-174.81%	-49.73%	-3755.85%
Interest Expense	$10.00K	-$380.0K	$0.00
YoY Change	-150.0%	153.33%	-100.0%
% of Operating Profit	0.69%
Other Income/Expense, Net	$7.000K	-$382.0K	$3.000K
YoY Change	-135.0%	161.64%	-93.48%
Pretax Income	$1.450M	-$1.593M	-$10.93M
YoY Change	-174.4%	-37.65%	-3267.54%
Income Tax	-$738.0K	$700.0K	$500.0K
% Of Pretax Income	-50.9%
Net Earnings	$2.188M	-$2.257M	-$11.39M
YoY Change	-204.79%	-14.12%	-2037.76%
Net Earnings / Revenue	4.38%	-5.77%	-43.21%
Basic Earnings Per Share	$0.12	-$0.13	-$0.67
Diluted Earnings Per Share	$0.12	-$0.13	-$0.67
COMMON SHARES
Basic Shares Outstanding	17.65M	17.60M shares	17.06M shares
Diluted Shares Outstanding	17.84M	17.60M shares	17.06M shares

Balance Sheet

Concept	2020 Q4	2020 Q3	2020 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$47.05M	$42.40M	$46.60M
YoY Change	38.78%	44.71%	47.0%
Cash & Equivalents	$47.05M	$29.39M	$33.66M
Short-Term Investments	$0.00	$13.00M	$12.90M
Other Short-Term Assets	$8.800M	$6.900M	$5.300M
YoY Change	57.14%	30.19%	17.78%
Inventory	$28.51M	$29.33M	$31.24M
Prepaid Expenses
Receivables	$21.96M	$17.60M	$13.83M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$106.3M	$96.26M	$96.93M
YoY Change	11.84%	4.72%	10.13%
LONG-TERM ASSETS
Property, Plant & Equipment	$2.299M	$2.391M	$2.417M
YoY Change	-18.39%	-13.71%	-14.71%
Goodwill	$1.300M	$1.339M	$1.339M
YoY Change	-2.91%	0.0%	0.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$5.080M	$5.290M	$4.733M
YoY Change	-20.76%	-17.47%	-25.0%
Total Long-Term Assets	$26.44M	$27.17M	$16.49M
YoY Change	41.43%	40.67%	-17.29%
TOTAL ASSETS
Total Short-Term Assets	$106.3M	$96.26M	$96.93M
Total Long-Term Assets	$26.44M	$27.17M	$16.49M
Total Assets	$132.7M	$123.4M	$113.4M
YoY Change	16.7%	10.96%	5.07%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$6.684M	$6.799M	$11.68M
YoY Change	-47.31%	-51.92%	2.1%
Accrued Expenses	$32.30M	$25.64M	$20.42M
YoY Change	6.56%	-8.73%	-24.43%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$3.630M	$400.0K	$500.0K
YoY Change		-33.33%	-16.67%
Total Short-Term Liabilities	$54.36M	$45.13M	$44.64M
YoY Change	-7.27%	-18.34%	-15.56%
LONG-TERM LIABILITIES
Long-Term Debt	$3.800M	$7.500M	$7.500M
YoY Change	533.33%	971.43%	837.5%
Other Long-Term Liabilities	$242.0K	$292.0K	$345.0K
YoY Change	-58.13%	-57.68%	-55.88%
Total Long-Term Liabilities	$242.0K	$292.0K	$345.0K
YoY Change	-58.13%	-57.68%	-55.88%
TOTAL LIABILITIES
Total Short-Term Liabilities	$54.36M	$45.13M	$44.64M
Total Long-Term Liabilities	$242.0K	$292.0K	$345.0K
Total Liabilities	$75.85M	$71.42M	$60.92M
YoY Change	11.88%	6.21%	-5.94%
SHAREHOLDERS EQUITY
Retained Earnings	-$60.24M	-$62.42M	-$60.17M
YoY Change	65.67%	82.15%	90.15%
Common Stock	$117.1M	$114.4M	$112.7M
YoY Change	42.2%	46.11%	50.45%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$56.88M	$52.01M	$52.50M
YoY Change
Total Liabilities & Shareholders Equity	$132.7M	$123.4M	$113.4M
YoY Change	16.7%	10.96%	5.07%

Cashflow Statement

Concept	2020 Q4	2020 Q3	2020 Q2
OPERATING ACTIVITIES
Net Income	$2.188M	-$2.257M	-$11.39M
YoY Change	-204.79%	-14.12%	-2037.76%
Depreciation, Depletion And Amortization	$330.0K	$340.0K	$360.0K
YoY Change	-10.81%	-5.56%	-12.2%
Cash From Operating Activities	$4.470M	-$3.450M	-$5.980M
YoY Change	12.59%	51.98%	-248.39%
INVESTING ACTIVITIES
Capital Expenditures	-$510.0K	-$330.0K	-$210.0K
YoY Change	8.51%	65.0%	-16.0%
Acquisitions
YoY Change
Other Investing Activities	$13.08M	-$140.0K	-$8.140M
YoY Change	-1257.52%	-94.19%	-304.01%
Cash From Investing Activities	$12.58M	-$490.0K	-$8.340M
YoY Change	-886.25%	-81.23%	-323.59%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	610.0K	-330.0K	33.22M
YoY Change	-42.45%	-430.0%	4389.19%
NET CHANGE
Cash From Operating Activities	4.470M	-3.450M	-5.980M
Cash From Investing Activities	12.58M	-490.0K	-8.340M
Cash From Financing Activities	610.0K	-330.0K	33.22M
Net Change In Cash	17.66M	-4.270M	18.90M
YoY Change	414.87%	-10.67%	122.35%
FREE CASH FLOW
Cash From Operating Activities	$4.470M	-$3.450M	-$5.980M
Capital Expenditures	-$510.0K	-$330.0K	-$210.0K
Free Cash Flow	$4.980M	-$3.120M	-$5.770M
YoY Change	12.16%	50.72%	-234.81%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2020Q4	us-gaap	Cash Cash	47047000	USD
CY2019Q4	us-gaap	Cash Cash	20005000	USD
CY2020Q4	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	47047000	USD
CY2019Q4	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	26316000	USD
CY2020Q4	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	0	USD
CY2019Q4	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	7605000	USD
CY2020Q4	cutr	Total Cash Cash Equivalents And Marketable Securities TotalCashCashEquivalentsAndMarketableSecurities	47047000	USD
CY2019Q4	cutr	Total Cash Cash Equivalents And Marketable Securities TotalCashCashEquivalentsAndMarketableSecurities	33921000	USD
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	47047000	USD
CY2020Q4	us-gaap	Cash And Cash Equivalents Fair Value Disclosure CashAndCashEquivalentsFairValueDisclosure	47047000	USD
CY2019Q4	us-gaap	Available For Sale Securities AvailableForSaleSecurities	7605000	USD
CY2019Q4	cutr	Cash Cash Equivalents And Marketable Investments Amortized Cost CashCashEquivalentsAndMarketableInvestmentsAmortizedCost	33921000	USD
CY2019Q4	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	0	USD
CY2019Q4	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	-0	USD
CY2019Q4	cutr	Cash And Cash Equivalents And Marketable Investments Fair Market Value CashAndCashEquivalentsAndMarketableInvestmentsFairMarketValue	33921000	USD
CY2019Q4	cutr	Debt Securities Availableforsale Net Accumulated Gross Unrealized Gain Loss Before Tax DebtSecuritiesAvailableforsaleNetAccumulatedGrossUnrealizedGainLossBeforeTax	0	USD
CY2020Q4	us-gaap	Marketable Securities MarketableSecurities	0	USD
CY2020Q4	cutr	Cash Cash Equivalents And Marketable Investments Amortized Cost CashCashEquivalentsAndMarketableInvestmentsAmortizedCost	47047000	USD
CY2020Q4	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	0	USD
CY2020Q4	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	-0	USD
CY2020Q4	cutr	Cash And Cash Equivalents And Marketable Investments Fair Market Value CashAndCashEquivalentsAndMarketableInvestmentsFairMarketValue	47047000	USD
CY2019Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	26316000	USD
CY2019Q4	us-gaap	Cash And Cash Equivalents Fair Value Disclosure CashAndCashEquivalentsFairValueDisclosure	26316000	USD
CY2019Q4	us-gaap	Available For Sale Securities Amortized Cost AvailableForSaleSecuritiesAmortizedCost	7605000	USD
CY2019Q4	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	0	USD
CY2019Q4	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	-0	USD
CY2019Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	5116000	USD
CY2020Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	3900000	USD
CY2019Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	2500000	USD
CY2020Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	12604000	USD
CY2019Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	13970000	USD
CY2020Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	14874000	USD
CY2019Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	17935000	USD
CY2020Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	1030000	USD
CY2019Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	2016000	USD
CY2019Q4	us-gaap	Inventory Net InventoryNet	33921000	USD
CY2020Q4	us-gaap	Inventory Net InventoryNet	28508000	USD
CY2020Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	12327000	USD
CY2019Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	11782000	USD
CY2020Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	10028000	USD
CY2019Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	8965000	USD
CY2020Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2299000	USD
CY2019Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2817000	USD
CY2020Q4	us-gaap	Goodwill Goodwill	1339000	USD
CY2020	us-gaap	Goodwill Period Increase Decrease GoodwillPeriodIncreaseDecrease	0	USD
CY2020	us-gaap	Goodwill And Intangible Asset Impairment GoodwillAndIntangibleAssetImpairment	0	USD
CY2020Q4	cutr	Accrued Sales And Marketing Costs Current AccruedSalesAndMarketingCostsCurrent	2352000	USD
CY2020Q4	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	12197000	USD
CY2019Q4	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	14341000	USD
CY2019Q4	cutr	Accrued Sales And Marketing Costs Current AccruedSalesAndMarketingCostsCurrent	2527000	USD
CY2020Q4	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	2908000	USD
CY2019Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	2800000	USD
CY2020Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	3630000	USD
CY2019Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	0	USD
CY2020Q4	us-gaap	Extended Product Warranty Accrual Current ExtendedProductWarrantyAccrualCurrent	1216000	USD
CY2019Q4	us-gaap	Extended Product Warranty Accrual Current ExtendedProductWarrantyAccrualCurrent	1999000	USD
CY2020Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	9489000	USD
CY2019Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	10831000	USD
CY2020Q4	us-gaap	Liabilities Current LiabilitiesCurrent	54358000	USD
CY2019Q4	us-gaap	Liabilities Current LiabilitiesCurrent	58622000	USD
CY2020Q4	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	1748000	USD
CY2019Q4	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	3391000	USD
CY2020Q4	us-gaap	Accrued Income Taxes Noncurrent AccruedIncomeTaxesNoncurrent	0	USD
CY2020Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	242000	USD
CY2019Q4	us-gaap	Accrued Income Taxes Noncurrent AccruedIncomeTaxesNoncurrent	93000	USD
CY2019Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	578000	USD
CY2020Q4	us-gaap	Liabilities Liabilities	75853000	USD
CY2019Q4	us-gaap	Liabilities Liabilities	67796000	USD
CY2020Q4	us-gaap	Common Stock Value CommonStockValue	18000	USD
CY2019Q4	us-gaap	Common Stock Value CommonStockValue	14000	USD
CY2020Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	117097000	USD
CY2019Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	82346000	USD
CY2020Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-60235000	USD
CY2019Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-36358000	USD
CY2020Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	0	USD
CY2019Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-60000	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	56880000	USD
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	45942000	USD
CY2020Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	132733000	USD
CY2019Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	113738000	USD
CY2020	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	147683000	USD
CY2019	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	181712000	USD
CY2018	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	162720000	USD
CY2019Q4	us-gaap	Sales And Excise Tax Payable Current SalesAndExciseTaxPayableCurrent	3922000	USD
CY2020Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	8779000	USD
CY2020Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2299000	USD
CY2019Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2817000	USD
CY2020Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	643000	USD
CY2019Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	423000	USD
CY2019Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	7702000	USD
CY2020Q4	us-gaap	Goodwill Goodwill	1339000	USD
CY2019Q4	us-gaap	Goodwill Goodwill	1339000	USD
CY2020Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	5080000	USD
CY2020	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	71911000	USD
CY2019Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	6411000	USD
CY2021Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	17782872
CY2020Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	1598000	USD
CY2019Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	1354000	USD
CY2020Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2019Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2020Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2019Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2020Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	50000000
CY2019Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	50000000
CY2020Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	17679232
CY2020Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	17679232
CY2019Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	14315586
CY2019Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	14315586
CY2020	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	2303000	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	56880000	USD
CY2019	us-gaap	Other Than Temporary Impairment Loss Debt Securities Available For Sale OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSale	0	USD
CY2018	us-gaap	Other Than Temporary Impairment Loss Debt Securities Available For Sale OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSale	0	USD
CY2020Q4	us-gaap	Lessor Operating Lease Term Of Contract LessorOperatingLeaseTermOfContract	P3Y
CY2020	cutr	Lessor Operating Lease Initial Term Of Contract LessorOperatingLeaseInitialTermOfContract	P12M
CY2020	cutr	Lessor Operating Lease Additional Term Month To Month Basis LessorOperatingLeaseAdditionalTermMonthToMonthBasis	P2Y
CY2019Q4	us-gaap	Goodwill Goodwill	1339000	USD
CY2019	us-gaap	Goodwill Period Increase Decrease GoodwillPeriodIncreaseDecrease	0	USD
CY2020	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	0	USD
CY2019	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	0	USD
CY2018	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	0	USD
CY2019	us-gaap	Goodwill And Intangible Asset Impairment GoodwillAndIntangibleAssetImpairment	0	USD
CY2020Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	17679232
CY2020Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2018	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	21.55
CY2020	us-gaap	Open Tax Year OpenTaxYear	2015 2016 2017 2018 2019 2020
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-23877000	USD
CY2019Q4	us-gaap	Litigation Reserve LitigationReserve	0	USD
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	47047000	USD
CY2019Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	26316000	USD
CY2020Q4	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	0	USD
CY2019Q4	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	7605000	USD
CY2020Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	21962000	USD
CY2019Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	21556000	USD
CY2020Q4	us-gaap	Inventory Net InventoryNet	28508000	USD
CY2019Q4	us-gaap	Inventory Net InventoryNet	33921000	USD
CY2019Q4	us-gaap	Assets Assets	113738000	USD
CY2020Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	6684000	USD
CY2019Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	12685000	USD
CY2019Q4	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	4401000	USD
CY2020Q4	us-gaap	Sales And Excise Tax Payable Current SalesAndExciseTaxPayableCurrent	5343000	USD
CY2020Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	31079000	USD
CY2020Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	8279000	USD
CY2019	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	83549000	USD
CY2018	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	82338000	USD
CY2020	us-gaap	Gross Profit GrossProfit	75772000	USD
CY2019Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	30307000	USD
CY2019Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	5648000	USD
CY2020Q4	us-gaap	Assets Current AssetsCurrent	106296000	USD
CY2019	us-gaap	Gross Profit GrossProfit	98163000	USD
CY2018	us-gaap	Gross Profit GrossProfit	80382000	USD
CY2020Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	17076000	USD
CY2019Q4	us-gaap	Assets Current AssetsCurrent	95046000	USD
CY2020	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	52766000	USD
CY2019	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	71109000	USD
CY2020Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	2260000	USD
CY2018	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	58420000	USD
CY2020	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	14322000	USD
CY2020Q4	us-gaap	Assets Assets	132733000	USD
CY2019	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	15085000	USD
CY2018	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	14359000	USD
CY2019Q4	us-gaap	Long Term Debt LongTermDebt	0	USD
CY2020Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	15950000	USD
CY2019Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	5112000	USD
CY2020Q4	us-gaap	Long Term Debt LongTermDebt	3555000	USD
CY2020	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	31512000	USD
CY2019	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	24033000	USD
CY2018	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	20995000	USD
CY2020	us-gaap	Operating Expenses OperatingExpenses	98600000	USD
CY2019	us-gaap	Operating Expenses OperatingExpenses	110227000	USD
CY2018	us-gaap	Operating Expenses OperatingExpenses	93774000	USD
CY2020	us-gaap	Operating Income Loss OperatingIncomeLoss	-22828000	USD
CY2019	us-gaap	Operating Income Loss OperatingIncomeLoss	-12064000	USD
CY2018	us-gaap	Operating Income Loss OperatingIncomeLoss	-13392000	USD
CY2020	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-579000	USD
CY2019	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-199000	USD
CY2018	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-123000	USD
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-23407000	USD
CY2019	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-12263000	USD
CY2018	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-13515000	USD
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	470000	USD
CY2019	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	85000	USD
CY2018	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	17255000	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-23877000	USD
CY2019	us-gaap	Net Income Loss NetIncomeLoss	-12348000	USD
CY2018	us-gaap	Net Income Loss NetIncomeLoss	-30770000	USD
CY2020	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-1.43
CY2019	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.88
CY2018	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-2.23
CY2020	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	16691000
CY2019	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	14096000
CY2018	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	13771000
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-23877000	USD
CY2019	us-gaap	Net Income Loss NetIncomeLoss	-12348000	USD
CY2018	us-gaap	Net Income Loss NetIncomeLoss	-30770000	USD
CY2020	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Reclassification Adjustments And Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsAndTax	-3000	USD
CY2019	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Reclassification Adjustments And Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsAndTax	9000	USD
CY2018	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Reclassification Adjustments And Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsAndTax	14000	USD
CY2020	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Before Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax	-63000	USD
CY2019	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Before Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax	-0	USD
CY2018	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Before Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax	-9000	USD
CY2020	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax	60000	USD
CY2019	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax	9000	USD
CY2018	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax	23000	USD
CY2020	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	60000	USD
CY2019	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	9000	USD
CY2018	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	23000	USD
CY2020	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-23817000	USD
CY2019	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-12339000	USD
CY2018	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-30747000	USD
CY2017Q4	us-gaap	Stockholders Equity StockholdersEquity	64893000	USD
CY2018	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	1681000	USD
CY2018	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	2718000	USD
CY2018	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	-3129000	USD
CY2018	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	7157000	USD
CY2018	us-gaap	Net Income Loss NetIncomeLoss	-30770000	USD
CY2018	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	23000	USD
CY2018Q4	us-gaap	Stockholders Equity StockholdersEquity	46386000	USD
CY2019	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	1281000	USD
CY2019	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	1613000	USD
CY2019	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	-831000	USD
CY2019	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	9832000	USD
CY2019	us-gaap	Net Income Loss NetIncomeLoss	-12348000	USD
CY2019	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	9000	USD
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	45942000	USD
CY2020	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	632000	USD
CY2020	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	947000	USD
CY2020	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	26495000	USD
CY2020	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	-3428000	USD
CY2020	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	10109000	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-23877000	USD
CY2020	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	60000	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-23877000	USD
CY2019	us-gaap	Net Income Loss NetIncomeLoss	-12348000	USD
CY2018	us-gaap	Net Income Loss NetIncomeLoss	-30770000	USD
CY2020	us-gaap	Share Based Compensation ShareBasedCompensation	10109000	USD
CY2019	cutr	Depreciation And Amortization Excluding Contract Acquisition Costs DepreciationAndAmortizationExcludingContractAcquisitionCosts	1548000	USD
CY2018	cutr	Depreciation And Amortization Excluding Contract Acquisition Costs DepreciationAndAmortizationExcludingContractAcquisitionCosts	1209000	USD
CY2020	us-gaap	Amortization Of Acquisition Costs AmortizationOfAcquisitionCosts	2593000	USD
CY2019	us-gaap	Share Based Compensation ShareBasedCompensation	9832000	USD
CY2018	us-gaap	Share Based Compensation ShareBasedCompensation	7157000	USD
CY2020	cutr	Depreciation And Amortization Excluding Contract Acquisition Costs DepreciationAndAmortizationExcludingContractAcquisitionCosts	1394000	USD
CY2019	us-gaap	Amortization Of Acquisition Costs AmortizationOfAcquisitionCosts	2915000	USD
CY2018	us-gaap	Amortization Of Acquisition Costs AmortizationOfAcquisitionCosts	1834000	USD
CY2020	us-gaap	Capitalized Computer Software Impairments1 CapitalizedComputerSoftwareImpairments1	805000	USD
CY2019	us-gaap	Capitalized Computer Software Impairments1 CapitalizedComputerSoftwareImpairments1	0	USD
CY2018	us-gaap	Capitalized Computer Software Impairments1 CapitalizedComputerSoftwareImpairments1	0	USD
CY2020	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	220000	USD
CY2019	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	-34000	USD
CY2018	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	-17438000	USD
CY2020	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	2144000	USD
CY2019	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	590000	USD
CY2018	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	1257000	USD
CY2020	cutr	Change In Rightofuse Asset And Liability Due To Modification ChangeInRightofuseAssetAndLiabilityDueToModification	2522000	USD
CY2019	cutr	Change In Rightofuse Asset And Liability Due To Modification ChangeInRightofuseAssetAndLiabilityDueToModification	2502000	USD
CY2018	cutr	Change In Rightofuse Asset And Liability Due To Modification ChangeInRightofuseAssetAndLiabilityDueToModification	0	USD
CY2020	us-gaap	Other Operating Activities Cash Flow Statement OtherOperatingActivitiesCashFlowStatement	513000	USD
CY2019	us-gaap	Other Operating Activities Cash Flow Statement OtherOperatingActivitiesCashFlowStatement	-83000	USD
CY2020	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	3164000	USD
CY2020	cutr	Increase Decrease In Extended Product Warranty Accrual IncreaseDecreaseInExtendedProductWarrantyAccrual	-783000	USD
CY2018	us-gaap	Other Operating Activities Cash Flow Statement OtherOperatingActivitiesCashFlowStatement	241000	USD
CY2020	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	2550000	USD
CY2019	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	2509000	USD
CY2018	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	117000	USD
CY2020	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-5413000	USD
CY2019	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	5907000	USD
CY2018	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-768000	USD
CY2019	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	1762000	USD
CY2018	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	1070000	USD
CY2020	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	2067000	USD
CY2019	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	3355000	USD
CY2018	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	2754000	USD
CY2020	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	-6034000	USD
CY2019	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	1406000	USD
CY2018	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	4277000	USD
CY2020	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	944000	USD
CY2019	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	7157000	USD
CY2018	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-3781000	USD
CY2019	cutr	Increase Decrease In Extended Product Warranty Accrual IncreaseDecreaseInExtendedProductWarrantyAccrual	-1160000	USD
CY2018	us-gaap	Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities	10050000	USD
CY2020	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	26060000	USD
CY2019	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	12687000	USD
CY2018	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	10874000	USD
CY2018	cutr	Increase Decrease In Extended Product Warranty Accrual IncreaseDecreaseInExtendedProductWarrantyAccrual	3159000	USD
CY2020	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	0	USD
CY2019	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	-140000	USD
CY2018	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	140000	USD
CY2020	cutr	Increase Decrease In Operating Lease Liabilities IncreaseDecreaseInOperatingLeaseLiabilities	-1598000	USD
CY2019	cutr	Increase Decrease In Operating Lease Liabilities IncreaseDecreaseInOperatingLeaseLiabilities	-2292000	USD
CY2018	cutr	Increase Decrease In Operating Lease Liabilities IncreaseDecreaseInOperatingLeaseLiabilities		USD
CY2020	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-2985000	USD
CY2019	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	1656000	USD
CY2018	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	1305000	USD
CY2020	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	-93000	USD
CY2019	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	-301000	USD
CY2018	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	15000	USD
CY2020	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-16934000	USD
CY2019	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-2217000	USD
CY2018	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	308000	USD
CY2020	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1279000	USD
CY2019	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	991000	USD
CY2018	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1488000	USD
CY2020	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	30000	USD
CY2019	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	45000	USD
CY2018	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	41000	USD
CY2020	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	5648000	USD
CY2019	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	0	USD
CY2018	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	13044000	USD
CY2020	us-gaap	Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities	28050000	USD
CY2019	us-gaap	Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities	14700000	USD
CY2020	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	6389000	USD
CY2019	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	1067000	USD
CY2018	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	10773000	USD
CY2020	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	1579000	USD
CY2019	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	2894000	USD
CY2018	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	4399000	USD
CY2020	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	7167000	USD
CY2019	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	0	USD
CY2018	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	0	USD
CY2020	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	28798000	USD
CY2019	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0	USD
CY2018	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0	USD
CY2020	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	2303000	USD
CY2019	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	-0	USD
CY2018	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	-0	USD
CY2020	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	3428000	USD
CY2019	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	831000	USD
CY2018	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	3129000	USD
CY2020	us-gaap	Repayments Of Long Term Capital Lease Obligations RepaymentsOfLongTermCapitalLeaseObligations	537000	USD
CY2019	us-gaap	Repayments Of Long Term Capital Lease Obligations RepaymentsOfLongTermCapitalLeaseObligations	649000	USD
CY2018	us-gaap	Repayments Of Long Term Capital Lease Obligations RepaymentsOfLongTermCapitalLeaseObligations	483000	USD
CY2020	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	31276000	USD
CY2019	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1414000	USD
CY2018	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	787000	USD
CY2020	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	20731000	USD
CY2019	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	264000	USD
CY2018	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	11868000	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	26316000	USD
CY2018Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	26052000	USD
CY2017Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	14184000	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	47047000	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	26316000	USD
CY2018Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	26052000	USD
CY2020	us-gaap	Interest Paid Net InterestPaidNet	63000	USD
CY2019	us-gaap	Interest Paid Net InterestPaidNet	81000	USD
CY2018	us-gaap	Interest Paid Net InterestPaidNet	85000	USD
CY2020	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	-1000	USD
CY2019	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	59000	USD
CY2018	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	472000	USD
CY2020	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	43000	USD
CY2019	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	738000	USD
CY2018	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	610000	USD
CY2020	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	11735000	USD
CY2019	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	0	USD
CY2018	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	0	USD
CY2020	us-gaap	Use Of Estimates UseOfEstimates	<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:5.7pt;margin-right:0pt;margin-top:0pt;text-align:justify;"><i><b>Use of Estimates</b></i></p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"><i><b> </b></i></p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:5.7pt;margin-right:0pt;margin-top:0pt;text-align:justify;">The preparation of consolidated financial statements in conformity with GAAP requires the Company’s management to make estimates and assumptions that affect the amounts reported of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the accompanying notes, and the reported amounts of revenue and expenses during the reported periods. Actual results could differ materially from those estimates.</p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:5.7pt;margin-right:0pt;margin-top:0pt;text-align:justify;"> </p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:5.7pt;margin-right:0pt;margin-top:0pt;text-align:justify;">On an ongoing basis, management evaluates its estimates, including those related to warranty obligations, sales commission, allowance for credit losses, sales allowances, valuation of inventories, fair value of goodwill, useful lives of property and equipment, impairment testing for long-lived-assets, implicit and incremental borrowing rates related to the Company’s leases, assumptions regarding variables used in calculating the fair value of the Company's equity awards, expected achievement of performance based vesting criteria, management performance bonuses, assumptions used in operating and sales-type lease classification, the standalone selling price of the Company's products and services, the period of benefit used to capitalize and amortize contract acquisition costs, variable consideration, contingent liabilities, recoverability of deferred tax assets, residual value of leased equipment, lease term and effective income tax rates. Management bases estimates on historical experience and on various other assumptions that are believed to be reasonable, the results of which form the basis for making judgments about the carrying values of assets and liabilities.</p>
CY2020	us-gaap	Capitalized Computer Software Impairments1 CapitalizedComputerSoftwareImpairments1	800000	USD
CY2020	us-gaap	Comparability Of Prior Year Financial Data ComparabilityOfPriorYearFinancialData	<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:5.7pt;margin-right:11.75pt;margin-top:0pt;text-align:justify;"><i><b>Comparability</b></i></p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:0pt;margin-right:11.75pt;margin-top:0pt;text-align:justify;"><i><b> </b></i></p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:5.7pt;margin-right:11.75pt;margin-top:0pt;text-align:justify;">The Company adopted the new lease standard effective <em style="font: inherit;"> January 1, 2019, </em>using the modified retrospective method. Prior period financial statements were <em style="font: inherit;">not</em> retrospectively restated. The financial results for the years ended <em style="font: inherit;"> December 31, 2020 </em>and <em style="font: inherit;">2019</em> were prepared using the new lease accounting standard whereas the financial results for the year ended <em style="font: inherit;"> December 31, 2018 </em>were prepared using prior effective guidance. As a result, the consolidated statement of operations for the years ended <em style="font: inherit;"> December 31, 2020 </em>and <em style="font: inherit;">2019</em> is <em style="font: inherit;">not</em> directly comparable to the consolidated statements of operations for the year ended <em style="font: inherit;"> December 31, 2018.</em></p>
CY2019Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	1400000	USD
CY2020Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	1600000	USD
CY2020	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	2100000	USD
CY2020	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	1200000	USD
CY2020Q4	us-gaap	Capitalized Contract Cost Net CapitalizedContractCostNet	3400000	USD
CY2019Q4	us-gaap	Capitalized Contract Cost Net CapitalizedContractCostNet	4600000	USD
CY2020	us-gaap	Other Than Temporary Impairment Loss Debt Securities Available For Sale OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSale	0	USD
CY2020	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:5.7pt;margin-right:0pt;margin-top:0pt;text-align:justify;"><i><b>Concentration of Credit Risk and Other Risks and Uncertainties</b></i></p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"><i><b> </b></i></p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:5.7pt;margin-right:0pt;margin-top:0pt;text-align:justify;">The Company operates in markets that are highly competitive and rapidly changing. Significant technological changes, shifting customer needs, the emergence of competitive products or services with new capabilities and other factors could negatively impact the Company’s operating results.</p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:5.7pt;margin-right:0pt;margin-top:0pt;text-align:justify;"> </p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:5.7pt;margin-right:0pt;margin-top:0pt;text-align:justify;">The Company is also subject to risks related to changes in the value of the Company’s significant balance of financial instruments. Financial instruments that potentially subject the Company to concentrations of risk consist principally of cash, cash equivalents, marketable investments, and accounts receivable. The Company’s cash and cash equivalents are primarily invested in deposits and money market accounts with <em style="font: inherit;">three</em> major financial institutions in the U.S. In addition, the Company has operating cash balances in banks in each of the international locations in which it operates. Deposits in these banks <em style="font: inherit;"> may </em>exceed the federally insured limits or any other insurance provided on such deposits, if any. Management believes that these financial institutions are financially sound and, accordingly, believes that minimal credit risk exists. To date, the Company has <em style="font: inherit;">not</em> experienced any losses on its deposits of cash and cash equivalents.</p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:5.7pt;margin-right:0pt;margin-top:0pt;text-align:justify;"> </p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:5.7pt;margin-right:0pt;margin-top:0pt;text-align:justify;">The Company invests in debt instruments, including bonds of the U.S. Government, its agencies, and its municipalities. The Company has also invested in other high grade investments such as commercial paper and corporate debt securities. The Company has established guidelines relative to credit ratings, diversification and maturities that seek to maintain safety and liquidity. By policy, the Company restricts its exposure to any single issuer by imposing concentration limits. To minimize the exposure due to adverse shifts in interest rates, the Company maintains investments at an average maturity of generally less than <em style="font: inherit;">twelve</em> months.</p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:5.7pt;margin-right:0pt;margin-top:0pt;text-align:justify;"> </p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:5.7pt;margin-right:0pt;margin-top:0pt;text-align:justify;">Accounts receivable are recorded net of an allowance for credit losses and are typically unsecured and are derived from revenue earned from worldwide customers. The Company controls credit risk through credit approvals, credit limits, and monitoring procedures. The Company performs credit evaluations of its customers and maintains an allowance for potential credit losses. As of <em style="font: inherit;"> December 31, 2020, </em>and <em style="font: inherit;">2019,</em> <em style="font: inherit;">no</em> customer represented more than <em style="font: inherit;">10%</em> of the Company’s net accounts receivable. During the years ended <em style="font: inherit;"> December 31, 2020, </em><em style="font: inherit;">2019,</em> and <em style="font: inherit;">2018,</em> domestic revenue accounted for 41%, 58% and 62%, respectively, of total revenue, while international revenue accounted for 59%, 42% and 38%, respectively, of total revenue. <em style="font: inherit;">No</em> single customer represented more than <em style="font: inherit;">10%</em> of total revenue for any of the years ended <em style="font: inherit;"> December 31, 2020, </em><em style="font: inherit;">2019</em> and <em style="font: inherit;">2018.</em></p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:5.7pt;margin-right:0pt;margin-top:0pt;text-align:justify;"> </p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:5.7pt;margin-right:0pt;margin-top:0pt;text-align:justify;"><i><b>Supplier concentration</b></i></p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"><i><b> </b></i></p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:5.7pt;margin-right:0pt;margin-top:0pt;text-align:justify;">The Company relies on <em style="font: inherit;">third</em> parties for the supply of components of its products, as well as <em style="font: inherit;">third</em>-party logistics providers. In instances where these parties fail to perform their obligations, the Company <em style="font: inherit;"> may </em>be unable to find alternative suppliers or satisfactorily deliver its products to its customers. The Company relies on <em style="font: inherit;">one</em> supplier for its <i>Secret</i> and <i>Secret PRO</i> products and <em style="font: inherit;">one</em> supplier for its skincare products.</p>
CY2020	us-gaap	Inventory Write Down InventoryWriteDown	800000	USD
CY2020Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	2200000	USD
CY2019Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	4100000	USD
CY2020	us-gaap	Depreciation Depreciation	1400000	USD
CY2019	us-gaap	Depreciation Depreciation	1500000	USD
CY2018	us-gaap	Depreciation Depreciation	1200000	USD
CY2020	us-gaap	Capitalized Computer Software Impairments1 CapitalizedComputerSoftwareImpairments1	800000	USD
CY2020	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	pure
CY2020	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	USD
CY2020	us-gaap	Advertising Expense AdvertisingExpense	1200000	USD
CY2019	us-gaap	Advertising Expense AdvertisingExpense	2800000	USD
CY2018	us-gaap	Advertising Expense AdvertisingExpense	2800000	USD
CY2020	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	pure
CY2020Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	17679232
CY2020Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000
CY2020Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	31079000	USD
CY2019Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	30307000	USD
CY2019Q4	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	4401000	USD
CY2018Q4	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	4666000	USD
CY2020	us-gaap	Standard Product Warranty Accrual Warranties Issued StandardProductWarrantyAccrualWarrantiesIssued	4475000	USD
CY2019	us-gaap	Standard Product Warranty Accrual Warranties Issued StandardProductWarrantyAccrualWarrantiesIssued	7629000	USD
CY2020	us-gaap	Standard Product Warranty Accrual Payments StandardProductWarrantyAccrualPayments	5968000	USD
CY2019	us-gaap	Standard Product Warranty Accrual Payments StandardProductWarrantyAccrualPayments	7894000	USD
CY2020Q4	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	2908000	USD
CY2019Q4	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	4401000	USD
CY2019Q4	us-gaap	Extended Product Warranty Accrual ExtendedProductWarrantyAccrual	4600000	USD
CY2019	us-gaap	Product Warranty Expense ProductWarrantyExpense	3200000	USD
CY2020	us-gaap	Extended Product Warranty Accrual Payments ExtendedProductWarrantyAccrualPayments	600000	USD
CY2019	us-gaap	Extended Product Warranty Accrual Payments ExtendedProductWarrantyAccrualPayments	1100000	USD
CY2020Q4	us-gaap	Revenue Remaining Performance Obligation Percentage RevenueRemainingPerformanceObligationPercentage	0.84	pure
CY2020Q4	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	11200000	USD
CY2019Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	14222000	USD
CY2018Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	12566000	USD
CY2020	cutr	Contract With Customer Liability Increase Advance Payments Received ContractWithCustomerLiabilityIncreaseAdvancePaymentsReceived	14131000	USD
CY2019	cutr	Contract With Customer Liability Increase Advance Payments Received ContractWithCustomerLiabilityIncreaseAdvancePaymentsReceived	17127000	USD
CY2020	cutr	Contract With Customer Liability Decrease From Revenue Deferred ContractWithCustomerLiabilityDecreaseFromRevenueDeferred	6337000	USD
CY2019	cutr	Contract With Customer Liability Decrease From Revenue Deferred ContractWithCustomerLiabilityDecreaseFromRevenueDeferred	6020000	USD
CY2020	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	10779000	USD
CY2019	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	9451000	USD
CY2020Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	11237000	USD
CY2020Q4	cutr	Capital Stock Shares Authorized CapitalStockSharesAuthorized	55000000
CY2020Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	50000000
CY2020Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2019Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	14222000	USD
CY2020	cutr	Deferred Revenue Costs Incurred DeferredRevenueCostsIncurred	8200000	USD
CY2019	cutr	Deferred Revenue Costs Incurred DeferredRevenueCostsIncurred	9300000	USD
CY2018	cutr	Deferred Revenue Costs Incurred DeferredRevenueCostsIncurred	7800000	USD
CY2020Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2020Q4	us-gaap	Preferred Stock No Par Value PreferredStockNoParValue	0.001
CY2017Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant	1494866
CY2017Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	839919
CY2018	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	81322
CY2018	cutr	Share Based Compensation Arrangement By Share Based Payment Award Shares Available For Grant In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesAvailableForGrantInPeriodGross	562070
CY2018	cutr	Share Based Compensation Arrangement By Based Payment Restricted Share Available For Grant Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByBasedPaymentRestrictedShareAvailableForGrantAwardOptionsForfeituresAndExpirationsInPeriod	148197
CY2020	cutr	Share Based Compensation Arrangement By Share Based Payment Award Shares Available For Grant In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesAvailableForGrantInPeriodGross	804949
CY2020	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	73227
CY2020	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	12.91
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	76553
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	76553
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	36.65
CY2017Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	16.46
CY2017	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P3Y11M26D
CY2017Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	24400000	USD
CY2018	cutr	Share Based Compensation Arrangement By Share Based Payment Shares Available For Grant Options Granted ShareBasedCompensationArrangementByShareBasedPaymentSharesAvailableForGrantOptionsGranted	21010
CY2018	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	21010
CY2018	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	50.65
CY2018	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	271902
CY2018	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	9.99
CY2018	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	81322
CY2018Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant	1141305
CY2018Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	507705
CY2018Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	20.52
CY2018	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P3Y6M7D
CY2018Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	2000000.00	USD
CY2019	cutr	Share Based Compensation Arrangement By Share Based Payment Shares Available For Grant Additional Shares Reserved ShareBasedCompensationArrangementByShareBasedPaymentSharesAvailableForGrantAdditionalSharesReserved	700000
CY2019	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	160798
CY2019	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	10.03
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	51208
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	51208
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	24.61
CY2019	cutr	Share Based Compensation Arrangement By Share Based Payment Award Shares Available For Grant In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesAvailableForGrantInPeriodGross	1538128
CY2019	cutr	Share Based Compensation Arrangement By Based Payment Restricted Share Available For Grant Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByBasedPaymentRestrictedShareAvailableForGrantAwardOptionsForfeituresAndExpirationsInPeriod	407320
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant	761705
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	295699
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	25.52
CY2019	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P3Y2M8D
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	3040000.00	USD
CY2020	cutr	Share Based Compensation Arrangement By Share Based Payment Shares Available For Grant Additional Shares Reserved ShareBasedCompensationArrangementByShareBasedPaymentSharesAvailableForGrantAdditionalSharesReserved	600000
CY2020	cutr	Share Based Compensation Arrangement By Share Based Payment Shares Available For Grant Options Granted ShareBasedCompensationArrangementByShareBasedPaymentSharesAvailableForGrantOptionsGranted	71088
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	71088
CY2020	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	14.85
CY2020	cutr	Share Based Compensation Arrangement By Based Payment Restricted Share Available For Grant Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByBasedPaymentRestrictedShareAvailableForGrantAwardOptionsForfeituresAndExpirationsInPeriod	522949
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant	1085170
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	217007
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	22.35
CY2020	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P3Y9M
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	1470000	USD
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	132641
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	24.60
CY2020	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P2Y10M2D
CY2020Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	1470000	USD
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	212025
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice	22.31
CY2020	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1	P3Y7M17D
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue	1451000000	USD
CY2020Q4	us-gaap	Share Price SharePrice	24.11
CY2019Q4	us-gaap	Share Price SharePrice	35.81
CY2020	us-gaap	Shares Paid For Tax Withholding For Share Based Compensation SharesPaidForTaxWithholdingForShareBasedCompensation	193573
CY2018	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	7157000	USD
CY2018Q4	us-gaap	Share Price SharePrice	17.02
CY2017Q4	us-gaap	Share Price SharePrice	45.35
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	400000	USD
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	1000000.0	USD
CY2018	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	8300000	USD
CY2020	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Lower Range Limit ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit	9.65
CY2020	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Upper Range Limit ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit	53.9
CY2020Q4	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions	217007
CY2020	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2	P3Y9M
CY2020Q4	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions	132641
CY2020	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	10109000	USD
CY2019	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	9832000	USD
CY2018	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	7157000	USD
CY2020	cutr	Proceeds From Issuance Of Shares Under Incentive And Sharebased Compensation Plans Including Stock Options Net ProceedsFromIssuanceOfSharesUnderIncentiveAndSharebasedCompensationPlansIncludingStockOptionsNet	1600000	USD
CY2019	cutr	Proceeds From Issuance Of Shares Under Incentive And Sharebased Compensation Plans Including Stock Options Net ProceedsFromIssuanceOfSharesUnderIncentiveAndSharebasedCompensationPlansIncludingStockOptionsNet	3900000	USD
CY2018	cutr	Proceeds From Issuance Of Shares Under Incentive And Sharebased Compensation Plans Including Stock Options Net ProceedsFromIssuanceOfSharesUnderIncentiveAndSharebasedCompensationPlansIncludingStockOptionsNet	1300000	USD
CY2020	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	10109000	USD
CY2019	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	9832000	USD
CY2019	us-gaap	Shares Paid For Tax Withholding For Share Based Compensation SharesPaidForTaxWithholdingForShareBasedCompensation	42695
CY2018	us-gaap	Shares Paid For Tax Withholding For Share Based Compensation SharesPaidForTaxWithholdingForShareBasedCompensation	77049
CY2020	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	3400000	USD
CY2019	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	800000	USD
CY2018	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	3100000	USD
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-25793000	USD
CY2019	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-13037000	USD
CY2018	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-14177000	USD
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	2386000	USD
CY2019	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	774000	USD
CY2018	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	662000	USD
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-23407000	USD
CY2019	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-12263000	USD
CY2018	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-13515000	USD
CY2020	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0	USD
CY2019	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0	USD
CY2018	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	-15000	USD
CY2020	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	-53000	USD
CY2019	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	101000	USD
CY2018	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	123000	USD
CY2020	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	747000	USD
CY2019	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	-76000	USD
CY2018	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	303000	USD
CY2020	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	694000	USD
CY2019	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	25000	USD
CY2018	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	411000	USD
CY2020	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	2000	USD
CY2019	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	2000	USD
CY2018	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	15674000	USD
CY2020	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	1000	USD
CY2019	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	1000	USD
CY2018	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	1230000	USD
CY2020	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	-227000	USD
CY2019	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	57000	USD
CY2018	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	-60000	USD
CY2020	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-224000	USD
CY2019	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	60000	USD
CY2018	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	16844000	USD
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	470000	USD
CY2019	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	85000	USD
CY2018	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	17255000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	18270000	USD
CY2019Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	14507000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	869000	USD
CY2019Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	1111000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Other DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther	3670000	USD
CY2019Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Other DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther	2202000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards DeferredTaxAssetsTaxCreditCarryforwards	12653000	USD
CY2019Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards DeferredTaxAssetsTaxCreditCarryforwards	11887000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Warranty Reserves DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsWarrantyReserves	976000	USD
CY2019Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Warranty Reserves DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsWarrantyReserves	924000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment	2191000	USD
CY2019Q4	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment	2354000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	979000	USD
CY2019Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	897000	USD
CY2020Q4	cutr	Deferred Tax Assets Operating Lease Liability DeferredTaxAssetsOperatingLeaseLiability	4311000	USD
CY2019Q4	cutr	Deferred Tax Assets Operating Lease Liability DeferredTaxAssetsOperatingLeaseLiability	3949000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	43919000	USD
CY2019Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	37831000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	38321000	USD
CY2019Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	32350000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	5598000	USD
CY2019Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	5481000	USD
CY2020Q4	cutr	Deferred Tax Liabilities Deferred Contract Acquisition Costs DeferredTaxLiabilitiesDeferredContractAcquisitionCosts	803000	USD
CY2019Q4	cutr	Deferred Tax Liabilities Deferred Contract Acquisition Costs DeferredTaxLiabilitiesDeferredContractAcquisitionCosts	1076000	USD
CY2020Q4	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Goodwill DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill	110000	USD
CY2019Q4	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Goodwill DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill	97000	USD
CY2020Q4	us-gaap	Deferred Tax Liabilities Leasing Arrangements DeferredTaxLiabilitiesLeasingArrangements	4042000	USD
CY2019Q4	us-gaap	Deferred Tax Liabilities Leasing Arrangements DeferredTaxLiabilitiesLeasingArrangements	3885000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	643000	USD
CY2019Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	423000	USD
CY2018	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	-0.0495	pure
CY2020	cutr	Effective Income Tax Rate Reconciliation Meals And Entertainment Percent EffectiveIncomeTaxRateReconciliationMealsAndEntertainmentPercent	-0.0065	pure
CY2020	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.2100	pure
CY2019	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.2100	pure
CY2018	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.2100	pure
CY2020	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.0277	pure
CY2019	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.0282	pure
CY2019	cutr	Effective Income Tax Rate Reconciliation Meals And Entertainment Percent EffectiveIncomeTaxRateReconciliationMealsAndEntertainmentPercent	-0.0283	pure
CY2018	cutr	Effective Income Tax Rate Reconciliation Meals And Entertainment Percent EffectiveIncomeTaxRateReconciliationMealsAndEntertainmentPercent	-0.0266	pure
CY2020	cutr	Effective Income Tax Rate Reconciliation Permanent Differences Percent EffectiveIncomeTaxRateReconciliationPermanentDifferencesPercent	-0.0287	pure
CY2019	cutr	Effective Income Tax Rate Reconciliation Permanent Differences Percent EffectiveIncomeTaxRateReconciliationPermanentDifferencesPercent	-0.0258	pure
CY2018	cutr	Effective Income Tax Rate Reconciliation Permanent Differences Percent EffectiveIncomeTaxRateReconciliationPermanentDifferencesPercent	0	pure
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost	-0.0107	pure
CY2019	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost	0.0378	pure
CY2018	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost	0.1366	pure
CY2020	cutr	Effective Income Tax Rate Reconciliation Return To Provision Percent EffectiveIncomeTaxRateReconciliationReturnToProvisionPercent	0	pure
CY2019	cutr	Effective Income Tax Rate Reconciliation Return To Provision Percent EffectiveIncomeTaxRateReconciliationReturnToProvisionPercent	0	pure
CY2018	cutr	Effective Income Tax Rate Reconciliation Return To Provision Percent EffectiveIncomeTaxRateReconciliationReturnToProvisionPercent	-0.0243	pure
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	-0.0105	pure
CY2019	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	-0.0034	pure
CY2018	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	0.0011	pure
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0.0015	pure
CY2019	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	-0.0033	pure
CY2018	cutr	Effective Income Tax Rate Reconciliation Valuation Allowance Percent EffectiveIncomeTaxRateReconciliationValuationAllowancePercent	-1.5549	pure
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Prior Year Income Taxes EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes	0.0040	pure
CY2019	us-gaap	Effective Income Tax Rate Reconciliation Prior Year Income Taxes EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes	0.0253	pure
CY2019Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	1426000	USD
CY2018Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	1563000	USD
CY2018	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	-0.0121	pure
CY2020	cutr	Effective Income Tax Rate Reconciliation Research And Development Percent EffectiveIncomeTaxRateReconciliationResearchAndDevelopmentPercent	0.0274	pure
CY2019	cutr	Effective Income Tax Rate Reconciliation Research And Development Percent EffectiveIncomeTaxRateReconciliationResearchAndDevelopmentPercent	0.0814	pure
CY2018	cutr	Effective Income Tax Rate Reconciliation Research And Development Percent EffectiveIncomeTaxRateReconciliationResearchAndDevelopmentPercent	0.0431	pure
CY2020	cutr	Effective Income Tax Rate Reconciliation Valuation Allowance Percent EffectiveIncomeTaxRateReconciliationValuationAllowancePercent	-0.2551	pure
CY2019	cutr	Effective Income Tax Rate Reconciliation Valuation Allowance Percent EffectiveIncomeTaxRateReconciliationValuationAllowancePercent	-0.3860	pure
CY2018	us-gaap	Effective Income Tax Rate Reconciliation Prior Year Income Taxes EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes	0	pure
CY2020	cutr	Effective Income Tax Rate Reconciliation Deferred Trueup Percent EffectiveIncomeTaxRateReconciliationDeferredTrueupPercent	0.0208	pure
CY2019	cutr	Effective Income Tax Rate Reconciliation Deferred Trueup Percent EffectiveIncomeTaxRateReconciliationDeferredTrueupPercent	0.0571	pure
CY2018	cutr	Effective Income Tax Rate Reconciliation Deferred Trueup Percent EffectiveIncomeTaxRateReconciliationDeferredTrueupPercent	0	pure
CY2020	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.0201	pure
CY2019	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.0070	pure
CY2018	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-1.2766	pure
CY2020Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	38300000	USD
CY2020	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	6000000.0	USD
CY2019	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	4500000	USD
CY2017Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	1519000	USD
CY2020	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	32000	USD
CY2019	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	291000	USD
CY2018	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	70000	USD
CY2019	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	25000	USD
CY2020	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	470000	USD
CY2019	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	129000	USD
CY2018	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	114000	USD
CY2020Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	1864000	USD
CY2019Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	1426000	USD
CY2018Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	1563000	USD
CY2020Q4	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	0	USD
CY2019	us-gaap	Net Income Loss NetIncomeLoss	-12348000	USD
CY2018	us-gaap	Net Income Loss NetIncomeLoss	-30770000	USD
CY2020	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	16691000
CY2019	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	14096000
CY2018	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	13771000
CY2020	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-1.43
CY2019	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.88
CY2018	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-2.23
CY2019	us-gaap	Defined Contribution Plan Employer Discretionary Contribution Amount DefinedContributionPlanEmployerDiscretionaryContributionAmount	400000	USD
CY2018	us-gaap	Defined Contribution Plan Employer Discretionary Contribution Amount DefinedContributionPlanEmployerDiscretionaryContributionAmount	400000	USD
CY2019	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1265000
CY2020	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1123000
CY2020	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	pure
CY2018	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1272000
CY2020	us-gaap	Defined Contribution Plan Employer Discretionary Contribution Amount DefinedContributionPlanEmployerDiscretionaryContributionAmount	200000	USD
CY2020	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	147683000	USD
CY2019	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	181712000	USD
CY2018	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	162720000	USD
CY2020	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	147683000	USD
CY2019	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	181712000	USD
CY2018	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	162720000	USD
CY2019Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	10049000	USD
CY2019Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	2430000	USD
CY2019Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	0	USD
CY2019Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	7759000	USD
CY2020Q4	us-gaap	Sales Type And Direct Financing Leases Lease Receivable SalesTypeAndDirectFinancingLeasesLeaseReceivable	683000	USD
CY2020Q4	us-gaap	Sales Type And Direct Financing Leases Lease Receivable Undiscounted Excess Amount SalesTypeAndDirectFinancingLeasesLeaseReceivableUndiscountedExcessAmount	107000	USD
CY2020Q4	cutr	Lease Rightofuse Asset LeaseRightofuseAsset	17543000	USD
CY2019Q4	cutr	Lease Rightofuse Asset LeaseRightofuseAsset	8710000	USD
CY2020Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	18210000	USD
CY2019Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	7912000	USD
CY2020Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	370000	USD
CY2019Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	541000	USD
CY2020Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	241000	USD
CY2019Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	578000	USD
CY2020Q4	us-gaap	Finance Lease Liability FinanceLeaseLiability	611000	USD
CY2019Q4	us-gaap	Finance Lease Liability FinanceLeaseLiability	1119000	USD
CY2020	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	431000	USD
CY2019	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	704000	USD
CY2020	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	63000	USD
CY2019	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	88000	USD
CY2020	us-gaap	Operating Lease Expense OperatingLeaseExpense	3275000	USD
CY2019	us-gaap	Operating Lease Expense OperatingLeaseExpense	2892000	USD
CY2020	us-gaap	Finance Lease Interest Payment On Liability FinanceLeaseInterestPaymentOnLiability	63000	USD
CY2019	us-gaap	Finance Lease Interest Payment On Liability FinanceLeaseInterestPaymentOnLiability	88000	USD
CY2020	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	537000	USD
CY2019	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	649000	USD
CY2020	us-gaap	Operating Lease Payments OperatingLeasePayments	2139000	USD
CY2019	us-gaap	Operating Lease Payments OperatingLeasePayments	2820000	USD
CY2020Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P6Y8M12D
CY2020Q4	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P2Y2M12D
CY2020Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.047	pure
CY2020Q4	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.056	pure
CY2020Q4	us-gaap	Sales Type And Direct Financing Leases Lease Receivable Payments To Be Received SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceived	790000	USD
CY2019Q4	us-gaap	Operating Expenses OperatingExpenses	30719000	USD
CY2019Q3	us-gaap	Operating Expenses OperatingExpenses	28642000	USD
CY2020Q4	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	4029000	USD
CY2020Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	3432000	USD
CY2020Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2991000	USD
CY2020	us-gaap	Operating Lease Lease Income OperatingLeaseLeaseIncome	367000	USD
CY2020Q4	us-gaap	Litigation Reserve LitigationReserve	400000	USD
CY2020Q4	us-gaap	Revenues Revenues	49943000	USD
CY2020Q3	us-gaap	Revenues Revenues	39132000	USD
CY2020Q2	us-gaap	Revenues Revenues	26369000	USD
CY2020Q1	us-gaap	Revenues Revenues	32239000	USD
CY2019Q4	us-gaap	Revenues Revenues	51795000	USD
CY2019Q3	us-gaap	Revenues Revenues	46117000	USD
CY2019Q2	us-gaap	Revenues Revenues	47774000	USD
CY2019Q1	us-gaap	Revenues Revenues	36026000	USD
CY2020Q4	us-gaap	Cost Of Revenue CostOfRevenue	21877000	USD
CY2020Q3	us-gaap	Cost Of Revenue CostOfRevenue	17386000	USD
CY2020Q2	us-gaap	Cost Of Revenue CostOfRevenue	14745000	USD
CY2020Q1	us-gaap	Cost Of Revenue CostOfRevenue	17903000	USD
CY2019Q4	us-gaap	Cost Of Revenue CostOfRevenue	23005000	USD
CY2019Q3	us-gaap	Cost Of Revenue CostOfRevenue	19884000	USD
CY2019Q2	us-gaap	Cost Of Revenue CostOfRevenue	21943000	USD
CY2019Q1	us-gaap	Cost Of Revenue CostOfRevenue	18717000	USD
CY2020Q4	us-gaap	Gross Profit GrossProfit	28066000	USD
CY2020Q3	us-gaap	Gross Profit GrossProfit	21746000	USD
CY2020Q2	us-gaap	Gross Profit GrossProfit	11624000	USD
CY2020Q1	us-gaap	Gross Profit GrossProfit	14336000	USD
CY2019Q4	us-gaap	Gross Profit GrossProfit	28790000	USD
CY2019Q3	us-gaap	Gross Profit GrossProfit	26233000	USD
CY2019Q2	us-gaap	Gross Profit GrossProfit	25831000	USD
CY2019Q1	us-gaap	Gross Profit GrossProfit	17309000	USD
CY2020Q4	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	14656000	USD
CY2020Q3	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	12286000	USD
CY2020Q2	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	11035000	USD
CY2020Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	14789000	USD
CY2019Q4	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	20323000	USD
CY2019Q3	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	17691000	USD
CY2019Q2	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	16992000	USD
CY2019Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	16104000	USD
CY2019Q2	us-gaap	Operating Expenses OperatingExpenses	25532000	USD
CY2020Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	7806000	USD
CY2019Q1	us-gaap	Operating Expenses OperatingExpenses	25335000	USD
CY2020Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	3870000	USD
CY2019Q4	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	4463000	USD
CY2019Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	3643000	USD
CY2019Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	3273000	USD
CY2019Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	3706000	USD
CY2020Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	1443000	USD
CY2020Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-1211000	USD
CY2019Q4	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	5933000	USD
CY2020Q4	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	7938000	USD
CY2020Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	7239000	USD
CY2020Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	8529000	USD
CY2019Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	7308000	USD
CY2019Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	5267000	USD
CY2019Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	5525000	USD
CY2020Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-10931000	USD
CY2020Q1	us-gaap	Operating Expenses OperatingExpenses	26465000	USD
CY2020Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-12336000	USD
CY2020Q4	us-gaap	Operating Expenses OperatingExpenses	26623000	USD
CY2020Q3	us-gaap	Operating Expenses OperatingExpenses	22957000	USD
CY2020Q2	us-gaap	Operating Expenses OperatingExpenses	22555000	USD
CY2020Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-12129000	USD
CY2019Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	-1929000	USD
CY2019Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-2409000	USD
CY2019Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	299000	USD
CY2019Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-8026000	USD
CY2020Q4	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	7000	USD
CY2020Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-382000	USD
CY2020Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	3000	USD
CY2020Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-207000	USD
CY2019Q4	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-20000	USD
CY2019Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-146000	USD
CY2019Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	46000	USD
CY2019Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-79000	USD
CY2020Q4	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	1450000	USD
CY2020Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-1593000	USD
CY2020Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-10928000	USD
CY2019Q4	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-1949000	USD
CY2019Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-2555000	USD
CY2019Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	345000	USD
CY2019Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-8105000	USD
CY2020Q4	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-738000	USD
CY2020Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	664000	USD
CY2020Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	466000	USD
CY2020Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	78000	USD
CY2019Q4	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	139000	USD
CY2019Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	73000	USD
CY2019Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-243000	USD
CY2019Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	115000	USD
CY2020Q4	us-gaap	Net Income Loss NetIncomeLoss	2188000	USD
CY2020Q3	us-gaap	Net Income Loss NetIncomeLoss	-2257000	USD
CY2020Q2	us-gaap	Net Income Loss NetIncomeLoss	-11394000	USD
CY2020Q1	us-gaap	Net Income Loss NetIncomeLoss	-12414000	USD
CY2019Q4	us-gaap	Net Income Loss NetIncomeLoss	-2088000	USD
CY2019Q3	us-gaap	Net Income Loss NetIncomeLoss	-2628000	USD
CY2019Q2	us-gaap	Net Income Loss NetIncomeLoss	588000	USD
CY2019Q1	us-gaap	Net Income Loss NetIncomeLoss	-8220000	USD
CY2020Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.12
CY2020Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.13
CY2020Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.67
CY2020Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.86
CY2019Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.15
CY2019Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.59
CY2019Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.19
CY2019Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.04
CY2020Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	17055000
CY2020Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	14433000
CY2020Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.12
CY2020Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.13
CY2020Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.67
CY2020Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.86
CY2019Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.15
CY2019Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.19
CY2019Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.04
CY2019Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.59
CY2020Q4	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	17653000
CY2020Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	17603000
CY2019Q4	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	14261000
CY2019Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	14182000
CY2019Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	14086000
CY2019Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	14017000
CY2020Q4	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	17840000
CY2020Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	17603000
CY2020Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	17055000
CY2020Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	14433000
CY2019Q4	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	14261000
CY2019Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	14182000
CY2019Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	14356000
CY2019Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	14017000

Files In Submission

Name	View Source	Status
0001437749-21-006866-index-headers.html	Edgar Link	pending
0001437749-21-006866-index.html	Edgar Link	pending
0001437749-21-006866.txt	Edgar Link	pending
0001437749-21-006866-xbrl.zip	Edgar Link	pending
cutr-20201231.xsd	Edgar Link	pending
cutr-20201231_cal.xml	Edgar Link	unprocessable
cutr-20201231_def.xml	Edgar Link	unprocessable
cutr-20201231_lab.xml	Edgar Link	unprocessable
cutr-20201231_pre.xml	Edgar Link	unprocessable
cutr20201231_10k.htm	Edgar Link	pending
cutr20201231_10kimg001.gif	Edgar Link	pending
cutr20201231_10k_htm.xml	Edgar Link	completed
ex_231255.htm	Edgar Link	pending
ex_231256.htm	Edgar Link	pending
ex_231257.htm	Edgar Link	pending
ex_231258.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$CUTR
CUTERA INC Stock $cutr

2020 Q4 Form 10-K Financial Statement

#000143774921006866 Filed on March 23, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CUTR CUTERA INC Stock $cutr

2020 Q4 Form 10-K Financial Statement

#000143774921006866 Filed on March 23, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CUTR
CUTERA INC Stock $cutr